MMedication Read More Over-the-counter ivermectin sales proposed in GeorgiaJanuary 31, 2026 ATLANTA, Ga. (Atlanta News First) — A Georgia state lawmaker wants to allow over-the-counter sales of a drug…
NNutrition Read More Supplement Recalled Over Potential ‘Life-Threatening’ Side Effects, FDA ReportsJanuary 25, 2026 The U.S. Food & Drug Administration has recalled a dietary supplement from Modern Warrior. The recall is due…
HHealthcare Read More AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD)January 9, 2026 Durham, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) — AB-1009 program advances to Phase 1/Phase 2; clinical trial initiated…
MMedication Read More Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag DisorderJanuary 8, 2026 WASHINGTON, Jan. 8, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has received…
HHealthcare Read More BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®January 7, 2026 BioXcel Therapeutics Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation…
MMedication Read More US FDA declines to approve Corcept’s drug for rare hormonal disorderJanuary 2, 2026 By Sneha S K and Sahil Pandey Dec 31 (Reuters) – The U.S. Food and Drug Administration has…
MMedication Read More Vanda Jumps 21% After FDA Approves Motion Sickness TherapyDecember 31, 2025 This article first appeared on GuruFocus. Vanda Pharmaceuticals (NASDAQ:VNDA) jumped roughly 21% in premarket trading after the U.S.…
MMedication Read More Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with HypercortisolismDecember 31, 2025 REDWOOD CITY, Calif., December 31, 2025–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery…
MMedication Read More Aptar’s Bidose Nasal System Delivers CARDAMYSTâ„¢ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)December 19, 2025 Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…
MMedication Read More FDA OKs libido-boosting pill for older women who have gone through menopauseDecember 15, 2025 WASHINGTON (AP) — U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido,…
HHealthcare Read More FDA recalling blood pressure medication used by thousands: Is your medicine affected?December 10, 2025 Check your medicine cabinets. More than 11,100 bottles of a type of blood pressure medication sold under the…
MMedication Read More US recalls popular blood pressure medication over fears of cross-contamination with another drugDecember 10, 2025 A commonly used blood pressure medication has been recalled over fears that it may be cross-contaminated with another…